{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965904",
  "id": "02965904",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250704",
  "time": "0824",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg88022kfm4w.pdf",
  "summary": "### Summary of ASX Announcement:  \n\n**Announcement Type:** Clinical Trial Update \u2013 PANCOSIL Study  \n\n**Material Information:**  \n- **Patient recruitment completed** for PANCOSIL trial (20 patients enrolled).  \n- **Preliminary data expected late 2025** \u2013 key catalyst for clinical/regulatory progress.  \n- **Novel CT-guided percutaneous delivery method** being evaluated \u2013 potential to simplify administration and expand market adoption.  \n\n**No material capital markets/trading impact identified** (no financing, timelines, or financial data disclosed).  \n\n*Omitted: Background details, leadership commentary, non-material operational updates.*",
  "usage": {
    "prompt_tokens": 1677,
    "completion_tokens": 132,
    "total_tokens": 1809,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T22:53:23.045589"
}